XML 41 R32.htm IDEA: XBRL DOCUMENT v3.22.2.2
Fair Value Measurements - Additional Information (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2022
Sep. 30, 2022
Sep. 30, 2021
Dec. 31, 2021
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]        
Accrued interest receivable excluded from fair value and amortized cost basis of available for sale securities $ 2,800 $ 2,800    
Write off of accrued interest receivable   0 $ 0  
Total unrealized gains recorded in accumulated other comprehensive income (loss)   11,600    
Brii Bio Parent [Member]        
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]        
Investment Owned At Fair Value 22,800 22,800    
Increase Decrease In Equity Securities Fv Ni 13,600 120,000    
Humabs        
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]        
Estimated fair value of contingent consideration $ 29,600 $ 29,600   $ 17,100
TomegaVax        
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]        
Asset Acquisition, Contingent Consideration, Liability       5,700
Maximum        
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]        
Securities contractual term 2 years 2 years    
Prepaid Expenses and Other Current Assets        
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]        
Accrued interest receivable excluded from fair value and amortized cost basis of available for sale securities       $ 1,100